EA199800057A1 - Применение производных пиррола, производные пиррола, способ их получения, фармацевтическая композиция на их основе и ассоциация производных пиррола с антиретровирусным агентом - Google Patents

Применение производных пиррола, производные пиррола, способ их получения, фармацевтическая композиция на их основе и ассоциация производных пиррола с антиретровирусным агентом

Info

Publication number
EA199800057A1
EA199800057A1 EA199800057A EA199800057A EA199800057A1 EA 199800057 A1 EA199800057 A1 EA 199800057A1 EA 199800057 A EA199800057 A EA 199800057A EA 199800057 A EA199800057 A EA 199800057A EA 199800057 A1 EA199800057 A1 EA 199800057A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pyrrol derivatives
derivatives
pyrrol
alkyl
association
Prior art date
Application number
EA199800057A
Other languages
English (en)
Inventor
Эрик Бак
Жорж Башиард
Норбер Дере
Консепсьон Немесек
Original Assignee
Рон-Пуленк Роре С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рон-Пуленк Роре С.А. filed Critical Рон-Пуленк Роре С.А.
Publication of EA199800057A1 publication Critical patent/EA199800057A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Новое терапевтическое применение производных пиррола общей формулы (I)в которой Het означает конденсированный с пирролом цикл, такой, что он образует пирролотиазольный, 5,6,7,8-тетрагидроиндолизиновый, дигидропирролотиазиновый или дигидропирролизиновый цикл; Rозначает карбоксамидогруппу, цианогруппу, карбоксил, алкоксикарбонил, ацил или имидазолилкарбонил; Rозначает атом водорода или галогена, или алкильный, алкенильный, тригалогенметильный радикал, или цианогруппу; Rозначает атом водорода или галогена, или гидроксильный, или алкильный радикал; и Het' означает пиридил, пиридил-N-оксид или тиазолил, причем алкильные или ацильные радикалы являются линейными или разветвленными (с 1-4 атомами углерода) и алкенильные радикалы являются линейными или разветвленными (с 2-4 атомами углерода), так же как их солей, когда они имеются, для получения лекарственного средства, предназначенного для лечения заболеваний, в которых принимает участие фактор некроза опухоли.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199800057A 1995-06-14 1996-06-12 Применение производных пиррола, производные пиррола, способ их получения, фармацевтическая композиция на их основе и ассоциация производных пиррола с антиретровирусным агентом EA199800057A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9507055A FR2735476B1 (fr) 1995-06-14 1995-06-14 Nouvelle application de derives du pyrrole
PCT/FR1996/000887 WO1997000073A1 (fr) 1995-06-14 1996-06-12 Nouvelle application de derives du pyrrole

Publications (1)

Publication Number Publication Date
EA199800057A1 true EA199800057A1 (ru) 1998-10-29

Family

ID=9479965

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800057A EA199800057A1 (ru) 1995-06-14 1996-06-12 Применение производных пиррола, производные пиррола, способ их получения, фармацевтическая композиция на их основе и ассоциация производных пиррола с антиретровирусным агентом

Country Status (19)

Country Link
US (1) US6194426B1 (ru)
EP (1) EP0833635A1 (ru)
JP (1) JP2001510437A (ru)
KR (1) KR19990022908A (ru)
AU (1) AU6309396A (ru)
BR (1) BR9609000A (ru)
CA (1) CA2221027A1 (ru)
CZ (1) CZ400697A3 (ru)
EA (1) EA199800057A1 (ru)
FR (1) FR2735476B1 (ru)
HU (1) HUP9901625A2 (ru)
IL (1) IL122560A0 (ru)
NO (1) NO975811D0 (ru)
PL (1) PL328669A1 (ru)
SK (1) SK171697A3 (ru)
TR (1) TR199701604T2 (ru)
TW (1) TW336935B (ru)
WO (1) WO1997000073A1 (ru)
ZA (1) ZA964932B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871537A (en) 1996-02-13 1999-02-16 Scimed Life Systems, Inc. Endovascular apparatus
FR2757166B1 (fr) * 1996-12-12 1999-01-29 Rhone Poulenc Rorer Sa Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2779724B1 (fr) * 1998-06-10 2001-04-20 Rhone Poulenc Rorer Sa Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent
US20040014744A1 (en) * 2002-04-05 2004-01-22 Fortuna Haviv Substituted pyridines having antiangiogenic activity
GB0816759D0 (en) * 2008-09-12 2008-10-22 Selcia Ltd Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931201A (en) * 1974-01-22 1976-01-06 The Dow Chemical Company Substituted pyridinyloxy(thio)phenyl -acetamides, -ureas and urea derivatives
FR2539417A1 (fr) * 1983-01-13 1984-07-20 Rhone Poulenc Sante Nouveaux pyrrolo-1, 2 heterocycles, leur preparation et les medicaments qui les contiennent
FR2557111B1 (fr) 1983-12-21 1986-04-11 Rhone Poulenc Sante Nouveaux derives ortho-condenses du pyrrole, leur preparation et les medicaments qui les contiennent
DK704488D0 (da) * 1988-12-19 1988-12-19 Novo Industri As Nye n-substituerede azaheterocykliske carboxylsyrer
FR2678834A1 (fr) * 1991-07-09 1993-01-15 Rhone Poulenc Rorer Sa Nouvelle application therapeutique du pyridylpyrrolothiazole carboxamide.

Also Published As

Publication number Publication date
NO975811L (no) 1997-12-10
CA2221027A1 (fr) 1997-01-03
PL328669A1 (en) 1999-02-15
WO1997000073A1 (fr) 1997-01-03
SK171697A3 (en) 1998-07-08
US6194426B1 (en) 2001-02-27
ZA964932B (en) 1997-01-06
JP2001510437A (ja) 2001-07-31
MX9709150A (es) 1998-03-31
FR2735476A1 (fr) 1996-12-20
AU6309396A (en) 1997-01-15
TW336935B (en) 1998-07-21
EP0833635A1 (fr) 1998-04-08
HUP9901625A2 (hu) 1999-09-28
TR199701604T2 (xx) 2000-10-23
NO975811D0 (no) 1997-12-10
FR2735476B1 (fr) 1997-07-18
IL122560A0 (en) 1998-06-15
CZ400697A3 (cs) 1998-03-18
KR19990022908A (ko) 1999-03-25
BR9609000A (pt) 1999-06-29

Similar Documents

Publication Publication Date Title
ATE178044T1 (de) Inhibitoren des arginin-ketoamid-enzyms
ES2080900T3 (es) Derivados piranicos utiles como inhibidores de 5-lipoxigenasa.
GEP20033053B (en) Substituted Pyrazoles as P38 Kinase Inhibitors, Methods for their Production, Pharmaceutical Compositions Containing Them and Methods for Treatment
PL306590A1 (en) Substituted heterocyclic carboxylamides, method obtaining them and their application as therapeutic agents
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
HUP0105414A2 (hu) Pirrolo-izokinolin-, azepino- és diazepino-indol-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
NO981911L (no) Anvendelse av rhodaninderivater for fremstilling av et medikament for behandling av Alzheimer's sykdom
ATE273279T1 (de) 2,3,5-trisubstituierte pyridine als inhibitoren von cyclooxygenase-2
AU2002314914A1 (en) Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
ATE226574T1 (de) 4,6-diarylpyrimidin-derivate und deren salze
DE69825154D1 (de) Pyridazinone als inhibitoren von cyclooxygenase-2
NO931317L (no) Et terapeutisk middel for parkinson's sykdom
FR2705343B1 (fr) Dérivés de beta,beta-diméthyl-4-pipéridineéthanamine, leur procédé de préparation et leur utilisation en thérapeutique.
KR950014067A (ko) 아릴아미드유도체
DE69131359D1 (de) Kondensierte Thiazolverbindungen, ihre Darstellung und ihre Anwendung
DE69413118D1 (de) Benzolsulfonamid-Derivate zur Behandlung der Blaseninstabilität
EA199800057A1 (ru) Применение производных пиррола, производные пиррола, способ их получения, фармацевтическая композиция на их основе и ассоциация производных пиррола с антиретровирусным агентом
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
ATE284684T1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
KR920019785A (ko) 벤조티아졸 유도체
ATE293602T1 (de) 2-aminopyridine als inhibitoren von cyclooxygenase-2
DE69119642T2 (de) Verwendung von Pyrido-Indol-Derivaten bei der Behandlung ischämischer Störungen
DE69619088T2 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
FR2663026B1 (fr) Derives de [(1-arylpyrrolidin-2-yl) methyl] piperazine, leur preparation et leur application en therapeutique.
ITMI920082A1 (it) Derivati solforati di acidi biliari